SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferation - Komatsu, Shiho; Nomiyama, Takashi; Numata, Tomohiro; Kawanami, Takako; Hamaguchi, Yuriko; Iwaya, Chikayo; Horikawa, Tsuyoshi; Fujimura-Tanaka, Yuki; Hamanoue, Nobuya; Motonaga, Ryoko; Tanabe, Makito; Inoue, Ryuji; et al. (ENDOCRINE JOURNAL, 2020)
Keywords: Breast cancer; Cell growth; Cell proliferation; Diabetes mellitus (non-insulin dependent); Glucagon; Glucagon-like peptide 1; Glucose; Hyperpolarization; Immunohistochemistry; Membrane potential; Mitochondria; Na+/glucose cotransporter; Polymerase chain reaction; Prostate cancer; SGLT2 inhibitor; siRNA; Mitochondria; Breast cancer; Membrane potential; SGLT2 inhibitor